|
WEE1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.105700E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.899040E-01 |
| Normal-vs-Stage2 |
1.707550E-02 |
| Normal-vs-Stage3 |
1.404850E-03 |
| Normal-vs-Stage4 |
1.561610E-03 |
| Stage1-vs-Stage2 |
1.726570E-01 |
| Stage1-vs-Stage3 |
4.358100E-03 |
| Stage1-vs-Stage4 |
6.921300E-03 |
| Stage2-vs-Stage3 |
8.829400E-01 |
| Stage2-vs-Stage4 |
8.167800E-01 |
| Stage3-vs-Stage4 |
8.856800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.072770E-01 |
| Normal-vs-AfricanAmerican |
6.087600E-01 |
| Normal-vs-Asian |
1.550030E-02 |
| Caucasian-vs-AfricanAmerican |
5.382800E-01 |
| Caucasian-vs-Asian |
1.654440E-01 |
| AfricanAmerican-vs-Asian |
1.215970E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.095200E-03 |
| Normal-vs-Female |
7.874100E-02 |
| Male-vs-Female |
2.282100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.488200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.739840E-03 |
| Normal-vs-Age(61-80Yrs) |
5.600600E-04 |
| Normal-vs-Age(81-100Yrs) |
2.421200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.403620E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.365200E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.214400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.909830E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.560800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.422600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.7437000000029E-05 |
| Classical-VS-Follicular |
4.096000E-02 |
| Classical-VS-Other |
9.939200E-01 |
| Classical-VS-Normal |
1.200410E-01 |
| Tall-VS-Follicular |
1.997980E-01 |
| Tall-VS-Other |
2.211600E-01 |
| Tall-VS-Normal |
1.035790E-04 |
| Follicular-VS-Other |
4.907400E-01 |
| Follicular-VS-Normal |
3.995500E-03 |
| Other-VS-Normal |
5.059000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.021200E-03 |
| Normal-vs-N1 |
4.298900E-03 |
| N0-vs-N1 |
9.336600E-01 |
|
|
